Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma

Table 4 Recovery analysis of Remdesivir and Levodropropizine by employing the recommended flourimetric approach and standard addition technique

Pharmaceutical (ng/mL)	Remdesivir		Levodropropizine
Pharmaceutical (ng/mL)	Pure added (ng/mL)	R%*	Pure added (ng/mL)	R%*
Remdesivir 50 (49.31) ^* Levodropropizine 30 (29.76) ^*	30	98.23	20	101.95
	50	98.3	30	101.73
	60	100.38	100	99.41
Mean		98.97		101.03
RSD%		1.235		1.394

ISSN: 2661-801X